Clinical trial NCT04714567 - References

Severe Asthma — Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients

Citation(s)

•   Drazen JM, Harrington D
  New Biologics for Asthma. N Engl J Med. 2018 Jun 28;378(26):2533-2534. doi: 10.1056/NEJMe1806037. Epub 2018 May 21.
•   Gliklich RE, Dreyer NA, Leavy MB, editors
  Registries for Evaluating Patient Outcomes: A User's Guide [Internet]. 3rd edition. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Available from http://www.ncbi.nlm.nih.gov/books/NBK208616/
•   Kerkhof M, Tran TN, Soriano JB, Golam S, Gibson D, Hillyer EV, Price DB
  Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population. Thorax. 2018 Feb;73(2):116-124. doi: 10.1136/thoraxjnl-2017-210531. Epub 2017 Sep 16.
•   Loureiro CC, Amaral L, Ferreira JA, Lima R, Pardal C, Fernandes I, Semedo L, Arrobas A
  Omalizumab for Severe Asthma: Beyond Allergic Asthma. Biomed Res Int. 2018 Sep 17;2018:3254094. doi: 10.1155/2018/3254094. eCollection 2018. Review.
•   Newby C, Heaney LG, Menzies-Gow A, Niven RM, Mansur A, Bucknall C, Chaudhuri R, Thompson J, Burton P, Brightling C; British Thoracic Society Severe Refractory Asthma Network
  Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability. PLoS One. 2014 Jul 24;9(7):e102987. doi: 10.1371/journal.pone.0102987. eCollection 2014.
•   Sá-Sousa A, Fonseca JA, Pereira AM, Ferreira A, Arrobas A, Mendes A, Drummond M, Videira W, Costa T, Farinha P, Soares J, Rocha P, Todo-Bom A, Sokolova A, Costa A, Fernandes B, Chaves Loureiro C, Longo C, Pardal C, Costa C, Cruz C, Loureiro CC, Lopes C, Mesquita D, Faria E, Magalhães E, Menezes F, Todo-Bom F, Carvalho F, Regateiro FS, Falcão H, Fernandes I, Gaspar-Marques J, Viana J, Ferreira J, Silva JM, Simão L, Almeida L, Fernandes L, Ferreira L, van Zeller M, Quaresma M, Castanho M, André N, Cortesão N, Leiria-Pinto P, Pinto P, Rosa P, Carreiro-Martins P, Gerardo R, Silva R, Lucas S, Almeida T, Calvo T
  The Portuguese Severe Asthma Registry: Development, Features, and Data Sharing Policies. Biomed Res Int. 2018 Nov 21;2018:1495039. doi: 10.1155/2018/1495039. eCollection 2018.
•   Sousa AS, Pereira AM, Fonseca JA, Azevedo LF, Abreu C, Arrobas A, Calvo T, Silvestre MJ, Cunha L, Falcão H, Drummond M, Geraldes L, Loureiro C; Severe Asthma Specialist Network (Rede de Especialistas de Asma Grave REAG)
  Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal. Rev Port Pneumol (2006). 2015 Apr 16. pii: S2173-5115(15)00080-9. doi: 10.1016/j.rppnen.2015.03.002. [Epub ahead of print]
•   Tay TR, Hew M
  Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation. Allergy. 2018 Jul;73(7):1369-1382. doi: 10.1111/all.13370. Epub 2017 Dec 15. Review.

Multidimensional Phenotyping of Severe Asthma Patients and Its Impact on Disease Control and Therapeutic Response - Analysis From the Portuguese Severe Asthma Registry

Details for clinical trial NCT04714567